李艳华

发布时间:2023年05月15日 11:10 点击: 来源:



姓名李艳华

职称:

副教授

专业:

分析化学

导:

硕导

最终学历:

博士研究生

联系电话

15376410900

电子邮件:

573162191@qq.com;

liyanhua@sdnu.edu.cn

简历及研究领域

个人简介:

202012月于山东师范大学获理学博士学位,20213月至今于山东师范大学化学化工与材料科学37000cm威尼斯工作。主讲课程:《分析化学实验》《仪器分析化学实验》。

研究领域:

主要围绕肿瘤的免疫治疗及细胞活性物质的检测和成像开展研究工作,相关研究已在Adv. Funct. Mater., Chem. Sci., Anal. Chem., Chem. Commun.等国际著名刊物发表文章20余篇。目前主持国家自然科学基金青年项目1项、山东省自然科学基金青年基金1项。

招生信息:

每年在分析化学专业招收学硕1-2名,在材料与化工专业招收专硕1-2,欢迎报考!

代表性论文

1. Yanhua Li, Xia Zhang, Xiuyan Wan, Xiaohan Liu, Wei Pan, Na Li*, and Bo Tang*, Inducing Endoplasmic Reticulum Stress to Expose Immunogens: A DNA Tetrahedron Nanoregulator for Enhanced Immunotherapy. Adv. Funct. Mater., 2020, 30 (48), 2000532.

2. Yanhua Li†, Xiaohan Liu†, Xia Zhang, Wei Pan, Na Li,* and Bo Tang*, Immune Cycle-Based Strategies for Cancer Immunotherapy. Adv. Funct. Mater., 2021, 31 (50), 2107540.

3. Yanhua Li, Shaohua Gong, Wei Pan, Yuanyuan Chen, Bo Liu, Na Li*, and Bo Tang*, A tumor acidity activatable and Ca2+-assisted immuno-nanoagent enhances breast cancer therapy and suppresses cancer recurrence. Chem. Sci., 2020, 11 (28), 7429-7437.

4. Yanhua Li†, Kun Tang†, Xia Zhang, Wei Pan, Na Li*, and Bo Tang*, A dendritic cell-like biomimetic nanoparticle enhances T cell activation for breast cancer immunotherapy. Chem. Sci., 2022, 13 (1), 105-110.

5. Yanhua Li†, Xia Zhang†, Xiaohan Liu, Wei Pan, Na Li*, and Bo Tang*, Intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy. Chem. Sci., 2021, 12 (9), 3130-3145.

6. Kun Tang†, Xia Zhang†, Jiaqi Yin, Wei Pan, Yanhua Li*, Na Li*, and Bo Tang*, A CaCO3-based synergistic immunotherapy strategy for treating primary and distal tumors. Chem. Commun., 2023, 59 (24), 3562-3565.

7. Xia Zhang, Jiaqi Yin, Wei Pan, Yanhua Li*, Na Li*, and Bo Tang, Imaging strategies for receptor tyrosine kinase dimers in living cells. Anal. Bioanal. Chem., 2023, 415 (1), 67-82.

8. Yanhua Li†, Kun Tang†, Xia Zhang, Wei Pan, Na Li*, and Bo Tang*, Tumor microenvironment responsive nanocarriers for gene therapy. Chem. Commun., 2022, 58 (63), 8754-8765.

9. Xia Zhang, Shenglin Wang, Kun Tang, Wei Pan, Huanjun Xu, Yanhua Li*, Yanan Gao*, Na Li*, and Bo Tang*, Cu2+ Embedded Three-Dimensional Covalent Organic Framework for Multiple ROS-Based Cancer Immunotherapy. ACS Appl. Mater. Interfaces, 2022, 14 (27), 30618-30625.

10. Yanhua Li†, Xiaohan Liu†, Xia Zhang, Wei Pan, Na Li*, and Bo Tang*, Immunogenic cell death inducers for enhanced cancer immunotherapy. Chem. Commun., 2021, 57 (91), 12087-12097.

11. Yanhua Li† Xia Zhang†, Xiaohan Liu, Wei Pan, Na Li*, and Bo Tang*, A mineralization strategy based on T-cell membrane coated CaCO3 nanoparticles against breast cancer and metastasis. Mater. Chem. Front., 2021, 5 (15), 5738-5745.

12. Yanhua Li†, Xia Zhang†, Wei Pan, Na Li*, and Bo Tang*, A Nongenetic Proximity-Induced FRET Strategy Based on DNA Tetrahedron for Visualizing the Receptor Dimerization. Anal. Chem., 2020, 92 (17), 11921-11926.

13. Yanhua Li†, Xiaohan Liu†, Wei Pan, Na Li*, and Bo Tang*, Photothermal therapy-induced immunogenic cell death based on natural melanin nanoparticles against breast cancer. Chem. Commun., 2020, 56 (9), 1389-1392.

14. Yanhua Li†, Na Li†, Wei Pan, Zhengze Yu, Limin Yang, and Bo Tang*, Hollow Mesoporous Silica Nanoparticles with Tunable Structures for Controlled Drug Delivery. ACS Appl. Mater. Interfaces, 2017, 9 (3), 2123-2129.

15. Yanhua Li, Yuanyuan Chen, Wei Pan, Zhengze Yu, Limin Yang, Hongyu Wang, Na Li*, and Bo Tang*, Nanocarriers with multi-locked DNA valves targeting intracellular tumor-related mRNAs for controlled drug release. Nanoscale, 2017, 9 (44), 17318-17324.

16. Yanhua Li†, Xia Zhang†, Xiaohan Liu, Wei Pan, Na Li*, and Bo Tang*, Designing and Engineering of Nanocarriers for Bioapplication in Cancer Immunotherapy. ACS Appl. Bio Mater., 2020, 3 (12), 8321-8337.

研究课题

国家自然科学基金青年基金项目

项目负责人,2023.01-2025.12

山东省自然科学基金青年基金项目

项目负责人,2022.01-2024.12





荣誉称号

山东省高等学校科学技术奖一等奖(第五位)

山东省教育厅

山东省研究生优秀成果一等奖(第一位)

山东省教育厅